Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources
NEW YORK/LONDON (Reuters) - Pfizer Incis the mystery bidder for Swedish Orphan Biovitrum AB , the rare disease specialist which disclosed this week that a potential buyer had made a preliminary...
Read more »